Hu, Yeshi <br/><br/>
Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways.  [electronic resource] 

 -  Pflugers Archiv : European journal of physiology  Jan 2008 
 - 607-16 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0031-6768 
<br/><br/><label>Standard No.: </label>10.1007/s00424-007-0321-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Benzophenanthridines--pharmacology<br/>Cardiotonic Agents--metabolism<br/>Cell Survival--drug effects<br/>Chromones--pharmacology<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Enzyme Activation<br/>Extracellular Signal-Regulated MAP Kinases--antagonists & inhibitors<br/>Flavonoids--pharmacology<br/>Glyburide--pharmacology<br/>Hydrogen Sulfide--metabolism<br/>Ischemic Preconditioning, Myocardial<br/>KATP Channels--antagonists & inhibitors<br/>Male<br/>Mitogen-Activated Protein Kinase 1--metabolism<br/>Mitogen-Activated Protein Kinase 3--metabolism<br/>Morpholines--pharmacology<br/>Myocardial Contraction--drug effects<br/>Myocardial Infarction--metabolism<br/>Myocardial Reperfusion Injury--metabolism<br/>Myocardium--enzymology<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Phosphorylation<br/>Potassium Channel Blockers--pharmacology<br/>Protein Kinase C--antagonists & inhibitors<br/>Protein Kinase Inhibitors--pharmacology<br/>Proto-Oncogene Proteins c-akt--antagonists & inhibitors<br/>Rats<br/>Rats, Sprague-Dawley<br/>Signal Transduction--drug effects<br/>Sulfides--metabolism<br/>Time Factors